Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David B Meya

Showing results (121-130 of 260) with videos related to

Pageof 26
Sort By:
AAS Open Research|March 13, 2025
COVID-19 and the HIV care continuum in Uganda: minimising collateral damageEnock Kagimu, Emily M Martyn, Jane Gakuru, et al.
Open Forum Infectious Diseases|October 21, 2022
Pregnancy-Related Tuberculous Meningitis and Immune Reconstitution Inflammatory Syndrome: A Case Series and Systematic ReviewKatelyn A Pastick, Enock Kagimu, Joanna Dobbin, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 12, 2015
Implementation and operational research: Integrated pre-antiretroviral therapy screening and treatment for tuberculosis and cryptococcal antigenemiaLincoln Pac, Mara Murray Horwitz, Anne Marion Namutebi, et al.
Plos Medicine|January 22, 2011
Clinical features and serum biomarkers in HIV immune reconstitution inflammatory syndrome after cryptococcal meningitis: a prospective cohort studyDavid R Boulware, David B Meya, Tracy L Bergemann, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 7, 2025
Predictive value of C-reactive protein for hospitalization and mortality among people with advanced HIV disease in Uganda receiving the WHO-recommended package of careElizabeth L Schwartz, Elizabeth K Nalintya, Caleb P Skipper, et al.
Medrxiv : the Preprint Server for Health Sciences|August 30, 2023
Divergent Neuroimmune Signatures in the Cerebrospinal Fluid Predict Differential Gender-Specific Survival Among Patients With HIV-Associated Cryptococcal MeningitisSamuel Okurut, David R Boulware, Elizabeth Okafor, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 7, 2018
Reflexive Laboratory-Based Cryptococcal Antigen Screening and Preemptive Fluconazole Therapy for Cryptococcal Antigenemia in HIV-Infected Individuals With CD4 <100 Cells/µL: A Stepped-Wedge, Cluster-Randomized TrialDavid B Meya, Agnes N Kiragga, Elizabeth Nalintya, et al.
Medical Mycology|November 4, 2015
Seroprevalence of histoplasmosis in Kampala, UgandaNathan C Bahr, George A Sarosi, David B Meya, et al.
Wellcome Open Research|August 12, 2022
Neurocognitive outcomes of tuberculous meningitis in a primarily HIV-positive Ugandan cohortCarson M Quinn, John Kasibante, Alice Namudde, et al.
Journal of Research in Nursing : JRN|August 16, 2021
The conundrum of clinical trials and standard of care in sub-Saharan Africa - the research nurse perspectiveJane Frances Ndyetukira, Richard Kwizera, Florence Kugonza, et al.
Pageof 26

Showing results (121-130 of 260) with videos related to

Sort By:
Pageof 26
AAS Open Research|March 13, 2025
COVID-19 and the HIV care continuum in Uganda: minimising collateral damageEnock Kagimu, Emily M Martyn, Jane Gakuru, et al.
Open Forum Infectious Diseases|October 21, 2022
Pregnancy-Related Tuberculous Meningitis and Immune Reconstitution Inflammatory Syndrome: A Case Series and Systematic ReviewKatelyn A Pastick, Enock Kagimu, Joanna Dobbin, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 12, 2015
Implementation and operational research: Integrated pre-antiretroviral therapy screening and treatment for tuberculosis and cryptococcal antigenemiaLincoln Pac, Mara Murray Horwitz, Anne Marion Namutebi, et al.
Plos Medicine|January 22, 2011
Clinical features and serum biomarkers in HIV immune reconstitution inflammatory syndrome after cryptococcal meningitis: a prospective cohort studyDavid R Boulware, David B Meya, Tracy L Bergemann, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 7, 2025
Predictive value of C-reactive protein for hospitalization and mortality among people with advanced HIV disease in Uganda receiving the WHO-recommended package of careElizabeth L Schwartz, Elizabeth K Nalintya, Caleb P Skipper, et al.
Medrxiv : the Preprint Server for Health Sciences|August 30, 2023
Divergent Neuroimmune Signatures in the Cerebrospinal Fluid Predict Differential Gender-Specific Survival Among Patients With HIV-Associated Cryptococcal MeningitisSamuel Okurut, David R Boulware, Elizabeth Okafor, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 7, 2018
Reflexive Laboratory-Based Cryptococcal Antigen Screening and Preemptive Fluconazole Therapy for Cryptococcal Antigenemia in HIV-Infected Individuals With CD4 <100 Cells/µL: A Stepped-Wedge, Cluster-Randomized TrialDavid B Meya, Agnes N Kiragga, Elizabeth Nalintya, et al.
Medical Mycology|November 4, 2015
Seroprevalence of histoplasmosis in Kampala, UgandaNathan C Bahr, George A Sarosi, David B Meya, et al.
Wellcome Open Research|August 12, 2022
Neurocognitive outcomes of tuberculous meningitis in a primarily HIV-positive Ugandan cohortCarson M Quinn, John Kasibante, Alice Namudde, et al.
Journal of Research in Nursing : JRN|August 16, 2021
The conundrum of clinical trials and standard of care in sub-Saharan Africa - the research nurse perspectiveJane Frances Ndyetukira, Richard Kwizera, Florence Kugonza, et al.
Pageof 26